SIGLEC1 and neoplasm: More interestingly, it has been demonstrated that CD169+ macrophages phagocytize dead tumor cells transported via lymphatic flow and present tumor-associated peptides to CD8+ T cells, whose cytotoxic activity is augmented, which is considered a crucial step for the induction of antitumor immunity [87,88].